What is the main purpose of this 8-K filing?

The main purpose of this 8-K filing is to disclose that WellPoint, Inc. (now Elevance Health) officers would be meeting with analysts and investors and intended to confirm the company's ability to meet its previously issued earnings expectations.

Does this filing provide updated financial results or guidance?

No, this filing does not provide updated financial results or new guidance. It specifically states that the company expects to confirm its ability to meet the earnings expectations previously communicated on April 26, 2006.

What does 'Regulation FD Disclosure' mean for investors?

Regulation FD (Fair Disclosure) requires that when a public company discloses material non-public information to securities market professionals or holders of its securities, it must make that information available to the public simultaneously. This filing ensures that the confirmation of meeting earnings expectations is made public, preventing selective disclosure.

Where can I find the original earnings expectations mentioned?

The original earnings expectations were provided in a press release and conference call on April 26, 2006. A copy of that press release was attached as Exhibit 99.1 to WellPoint's Form 8-K filed on April 26, 2006.

ELV 8-K: Regulation FD — Jun 12, 2006

Summary

This 8-K filing from WellPoint, Inc. (which later became Elevance Health) on June 12, 2006, primarily serves as a Regulation FD disclosure. The company's officers were scheduled to meet with securities analysts and investors between June 12 and June 30, 2006. The key takeaway for investors is that WellPoint expected to reaffirm its previously issued earnings guidance from an April 26, 2006, press release and conference call. This proactive communication indicates the company's confidence in its financial performance and its commitment to transparency with the investment community. While no new financial figures or material business developments were announced in this specific 8-K, the confirmation of meeting earnings expectations is a positive signal for shareholders and potential investors.

Key Highlights

1Company confirming ability to meet previously issued earnings expectations.
2Meetings scheduled with securities analysts and investors from June 12 to June 30, 2006.
3Disclosure made under Regulation FD to ensure fair dissemination of information.
4Reaffirmation of guidance originally provided on April 26, 2006.
5No new material financial information or business updates were disclosed in this filing.
6Filed by WellPoint, Inc. (now Elevance Health) on June 12, 2006.

Elevance Health, Inc. 8-K Report, Regulation FD Disclosure (Jun 12, 2006)

Summary

Key Highlights

Frequently Asked Questions